To further its mission of facilitating timely and broad dissemination of kidney science, the American Society of Nephrology (ASN) today announced an addition to its journal portfolio, Kidney360. The journal will available online monthly beginning January 2020.
• In a study of young adults with kidney failure, poor wellbeing and lower medication adherence were both associated with psychological morbidity. • Dialysis treatment (vs. kidney transplantation) was associated with poorer wellbeing and medication adherence.
In 2016, the ASN Foundation for Kidney Research launched the Securing the Future Campaign with the goal to endow the Career Development Grants Program. The campaign has since raised more than $22 million through generous contributions from industry, individual donors, and the American Society of Nephrology (ASN).
The American Society of Nephrology (ASN), the world’s largest organization of kidney health professionals, released a new report on the annual survey of nephrology fellows authored by George Washington University (GW) researchers.
Adult patients who received liver and kidney transplants at Rush University Medical Center had better-than-expected one-year survival rates, according to the most recent transplantation on the 5-tier system report by the Scientific Registry of Transplant Recipients (SRTR), which was released on Oct. 9.
• Certain parameters measured by ultrasound helped predict the success of an arteriovenous fistula, the preferred type of hemodialysis vascular access, in individual patients.
Description: Papers on carcinogenesis; organophosphate flame retardants and zebrafish behavior; AHR gene targeting and hepatotoxicity; nontoxic substructures; and genistein and type 1 diabetes featured in latest issue of Toxicological Sciences.
• In a multi-ethnic study of individuals without kidney disease, high blood levels of an inflammatory marker, sTNFR-1, were associated with greater kidney function decline over time. • This association was independent of previously known risk factors for kidney disease progression and persisted across multiple sub-groups of participants.
Penn Medicine experts in nephrology and health policy call for more transparency about joint-venture ownership of dialysis clinics to better understand what impact these arrangements may have on patient referrals and clinical outcomes. The lack of transparency poses a major barrier for evidence-based health care policy research and deprives patients of critical information, the researchers write in a new Perspective published in the New England Journal of Medicine.
By investigating how genetic variations drive the expression of genes within the filtering cells of the kidney, researchers have found new pathways to explain CKD development and could inform its treatment.
The American Society of Nephrology (ASN), the world’s largest organization of kidney health professionals, released a new analysis of early career nephrologists authored by George Washington University (GW) researchers. GW’s report details significant differences between nephrologists beginning their careers in group practices compared to those starting in academic positions. The report noted the differences between these two groups of nephrologists included income, hours worked, job satisfaction, and whether they would recommend the specialty. More than 40 million Americans have kidney diseases, the 9th leading cause of death in the U.S.
The American Thyroid Association (ATA) announces with pleasure that the 2018 John B. Stanbury Thyroid Pathophysiology Medal will be awarded to Dr. Marvin C. Gershengorn at the ATA Annual Meeting this week. Dr. Gershengorn is Chief of the Clinical Endocrinology Branch (formerly the Laboratory of Endocrinology and Receptor Biology) at the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland.
Participants from Congress, HHS, NIH, and the kidney community discussed greater coordination among public and private institutions to increase innovation in kidney care and research
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
• Among patients with kidney failure on dialysis, use of proton pump inhibitors was associated with a 19% higher risk of hip fracture. The association remained within subgroups of low, moderate, and high use, yielding of 16%, 21%, and 19% greater risks, respectively. • Histamine-2 receptor antagonists were not associated with hip fracture events.
The prevalence of kidney diseases in the United States is at a record high. As such, members of “kidney community” healthcare groups, including the American Society of Nephrology (ASN), will meet with Congress on Capitol Hill to commend them for a $2 billion funding increase for the NIH with an at least proportional increase for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and advocate for increased innovation in kidney medicine, including the Kidney Innovation Accelerator (KidneyX), and passage of the Living Donor Protection Act of 2017 (H.R. 1270).
The lives of two healthcare caregivers changed in two different, dramatic ways, thanks to generous organ donation.
根据发表在《美国肾脏病学会临床杂志》（Clinical Journal of the American Society of Nephrology）上的一项Mayo Clinic的研究显示，接受手术切除卵巢的绝经前妇女患慢性肾病的风险会增加。
Jacqueline Chang, MD, a pulmonologist at Beth Israel Deaconess Medical Center, shares common triggers of Restless Leg Syndrome (RLS).
• Among children on dialysis for end-stage kidney failure, patients with vasculitis, ischemic kidney failure, and hemolytic uremic syndrome were most likely to regain kidney function and no longer need dialysis. • Younger age and initiation on hemodialysis instead of peritoneal dialysis were also associated with recovery of kidney function.
Scientists, clinicians, and other members of the international kidney health community will join forces in sunny southern California this October 23–28 for the American Society of Nephrology’s (ASN) Kidney Week 2018. Held in San Diego, this largest event of its kind offers a forum to share and hear advances in basic, clinical, and translational research, and to discover the latest innovations in clinical practice.
De acuerdo al estudio de Mayo Clinic publicado el miércoles 19 de septiembre en el Clinical Journal of the American Society de Nephrology, la extirpación quirúrgica de los ovarios durante la perimenopausia incrementa el riesgo de que las mujeres desarrollen insuficiencia renal crónica.
روتشستر، مينيسوتا - النساء اللواتي قمن بإستئصال المبيضين قبل انقطاع الطمث يواجهن خطر الإصابة بأمراض الكلى المزمنة بصورة متزايدة وفقًا للدراسات التي أجرتها Mayo Clinic وتم نشرها في Clinical Journal of the American Society of Nephrology.
Mulheres na pré-menopausa que passaram por uma cirurgia para remoção do ovário enfrentam um maior risco de desenvolver a doença renal crônica, segundo o estudo da Mayo Clinic publicado no Clinical Journal of the American Society of Nephrology.
ROCHESTER, Minn. — Premenopausal women who have their ovaries surgically removed face an increased risk of developing chronic kidney disease, according to a Mayo Clinic study published on Wednesday, Sept. 19, in the Clinical Journal of the American Society of Nephrology.
• On the 10th anniversary of the Renal Fellow Network (RFN), one of the first nephrology blogs, the American Society of Nephrology has created a partnership with RFN to continue its legacy and forge new opportunities.
In an analysis of all relevant studies, exposure to environmental toxins called per- and polyfluoroalkyl substances was linked to worse kidney function and other signs of kidney damage.
The Keck School of Medicine of USC has received a generous $100,000 donation from PUMA for the Selena Gomez Fund for Lupus Research, two years after the singer/actress established the fund.
American Society of Nephrology (ASN) publications contribute to the improved health of more than 850,000,000 people worldwide affected by kidney diseases—including 40 million Americans.
Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at The University of Texas MD Anderson Cancer Center, has been recognized for her innovative work understanding factors that enhance and hinder cancer immunotherapy. Sharma will receive the William B. Coley Award for Distinguished Research in Tumor Immunology, awarded annually by the Cancer Research Institute (CRI), at an annual meeting co-sponsored by CRI in New York Sept. 30 to Oct. 3.
Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other cancers by regulating a form of cell death called ferroptosis, opening up a potential new area of therapy research. Findings from the study, led by Boyi Gan, Ph.D., associate professor, Department of Experimental Radiation Oncology, were published in the Sept. 10 online issue of Nature Cell Biology.
The National Institutes of Health (NIH) has awarded New York University nearly $66 million over the next five years to study how exposure to environmental factors influences children’s health. This new funding is an extension of a previous award of nearly $15 million over the last two years from an NIH initiative called Environmental influences on Child Health Outcomes (ECHO), which investigates how a range of environmental factors in early development – from conception through early childhood – affects the health and development of children and adolescents.
A grant from the National Institutes of Health (NIH) will help a University of New Hampshire researcher better understand dehydration and ultimately help humans better survive it by studying a tiny desert rodent that’s adapted to survive both acute and chronic dehydration.
A team of investigators used intraoperative infusions of labeled glucose in patients about to have surgery to remove the kidney cancer to assess how the tumors use glucose.
A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.
A new device allows surgeons to create an access point for dialysis patients using a minimally-invasive approach. This might help the more than 470,000 currently on dialysis.
Of the many well-documented risks of dirty air, one potential danger is lesser known: chronic kidney disease. Learn about new research and how to protect yourself.
•On a national level, implementation of antimicrobial stewardships in outpatient dialysis facilities would result in 2182 fewer infections caused by multidrug-resistant organisms and Clostridium difficile (a 4.8% reduction) per year. • It would also lead to 629 fewer infection-related deaths (a 4.6% reduction) and a cost savings of $99,804,603 (a 4.7% reduction) per year.
Although black and Hispanic veterans with chronic kidney disease (CKD) are more likely than white patients to see a kidney specialist—a nephrologist—they are more likely to suffer disease progression from early stage to advanced kidney disease, reports a study published this month in the Journal of the American Society of Nephrology from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Researchers at University of California San Diego School of Medicine and the University of Alabama at Birmingham School of Medicine (UAB) have received renewed grant funding from the National Institute of Diabetes and Digestive and Kidney Diseases to expand research into the areas of acute kidney failure and acute kidney injuries.
A multidisciplinary research team led by Beth Israel Deaconess Medical Center has determined that vitamin B3 has the potential to prevent acute kidney injury. Published in Nature Medicine, the findings bring clinicians one step closer to an accessible and safe therapy for patients who may be at risk.
A Mayo Clinic foi eleita o melhor hospital do país na 29ª lista de honra dos melhores hospitais dos EUA do periódico U.S. News & World Report. A Mayo Clinic também ficou em primeiro lugar em mais especialidades do que qualquer outro hospital dos EUA.
A team of investigators led by Beth Israel Deaconess Medical Center (BIDMC) medical oncologist Rupal Bhatt, MD, PhD, has demonstrated that a molecule called KIM-1, a protein present in the blood of some patients with renal cell carcinoma is present at elevated levels at the time of diagnosis, can also serve as a tool to predict the disease’s onset up to five years prior to diagnosis
The American Thyroid Association has awarded a 2018 Research Grant to Nicholas J. Tardi, PhD, Instructor in Internal Medicine at Rush University Medical Center in Chicago. Dr. Tardi’s project is titled “Deiodinase 3: A Thyroid Hormone-Associated Renoprotective Protein.” The long-term goal of this project is to identify the source and mechanism of kidney and thyroid comorbidity. Thyroid hormone (TH) is a circulating, lipid-soluble molecule that plays an important physiological and developmental role in nearly all cells. Accordingly, precise control of TH activity is crucial to maintain metabolic homeostasis in several tissues.
PHOENIX ─ Mayo Clinic Hospital, Phoenix, Arizona is again ranked No. 1 in Arizona and the Phoenix metro area, and No. 11 nationally by U.S. News & World Report. This marks the second time Mayo Clinic has been recognized with two hospitals on U.S. News & World Report's "Best Hospitals Honor Roll," which includes the top 20 hospitals in the nation. Mayo Clinic’s campus in Rochester, Minnesota, ranked No. 1 nationally. The results were announced today on the U.S. News & World Report web site.
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those most at risk for 30-day readmission, researchers from UT Southwestern found.
• Older adults who initiate dialysis for kidney failure face a higher likelihood of being diagnosed with dementia and Alzheimer’s disease. • Certain risk factors were linked this higher risk. • Older hemodialysis patients with a diagnosis of dementia or Alzheimer’s disease had a high risk of early death.
Older kidney disease patients who are sick enough to require the blood-filtering treatment known as dialysis are at high risk of dementia, including Alzheimer’s disease, according to a study led by scientists at Johns Hopkins Bloomberg School of Public Health.
Penn Team Eradicates Hepatitis C in 20 Patients Following Lifesaving Transplants from Infected Donors
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right